Journal of the Peripheral Nervous System

Papers
(The median citation count of Journal of the Peripheral Nervous System is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Loss of function MPZ mutation causes milder CMT1B neuropathy302
Issue Information51
Issue Information48
31
Featured Cover30
23
20
Lack of effect from genetic deletion of Hdac6 in a humanized mouse model of CMT2D19
A severe case of neuroleukemiosis caused by B cell chronic lymphocytic leukemia, presenting as mononeuritis multiplex18
16
ABSTRACT15
Abstracts15
Toxic medications in Charcot–Marie–Tooth patients: A systematic review15
The autoimmune vulnerability of the node of Ranvier14
A recurrent MORC2 mutation causes Charcot‐Marie‐Tooth disease type 2Z14
Long‐term and low‐dose rituximab treatment for chronic inflammatory demyelinating polyneuropathy12
12
Sural nerve biopsy utility by masked assessment of individual histologic preparations12
PNS Abstracts 202311
Identical late motor responses in early Guillain‐Barré syndrome: A‐waves and repeater F‐waves11
Issue Information10
Evidence for spontaneous regulation of the humoral IgM anti‐GM1 autoimmune response by IgG antibodies in multifocal motor neuropathy patients10
10
Prognostic value of neurofilament light in blood in patients with polyneuropathy: A systematic review9
Phase 2a randomized controlled study investigating the safety and efficacy of PDA‐002 in diabetic peripheral neuropathy9
Electrodiagnostic methods to verify Guillain‐Barré syndrome subtypes in Istanbul: A prospective multicenter study9
9
Variations within Toll‐like receptor (TLR) and TLR signaling pathway‐related genes and their synergistic effects on the risk of Guillain‐Barré syndrome8
Analysis of relapse by inflammatory Rasch‐built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy8
Frequency dependent, reversible focused ultrasound suppression of evoked potentials in the reflex arc in an anesthetized animal8
Antecedent infections in Guillain‐Barré syndrome in endemic areas of arbovirus transmission: A multinational case‐control study8
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy‐induced peripheral neurotoxicity: The role of nerve excitability testing8
Recruiting for an International Rare Disease Clinical Trial Readiness Study during the COVID‐19 pandemic: Challenges and solutions8
Reply to “Nerve ultrasound as a screening tool for inherited sensory neuronopathy”7
Somatosensory profiling of patients undergoing alcohol withdrawal: Do neuropathic pain and sensory loss represent a problem?7
Oxygen matters: Unraveling the role of oxygen in the neuronal response to cisplatin7
Neuralgic amyotrophy presentation of acute intermittent porphyria: A case report7
Retrospective analysis of response to rituximab in chronic inflammatory demyelinating polyneuropathy refractory to first‐line therapy7
Hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE‐CIDP 1 randomized controlled tria6
Validation of the Korean version of inflammatory Rasch‐built Overall Disability Scale in patients with inflammatory neuropathy6
Broadening Research Priorities in Peripheral Neuropathy: A Response to “A Call to Action for Peripheral Neuropathy Research Funding—Time to Consolidate Funding Under One NIH Initiative?”6
Distinguishing Chronic Inflammatory Demyelinating Polyneuropathy From Mimic Disorders: The Role of Statistical Modeling6
Reply to the Letter to the Editor “Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?” by Kokubun N. et al.6
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy6
Featured Cover5
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po5
Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy: Reply to Letter to the Editor5
Electrodiagnostic subtyping in Guillain‐Barré syndrome: Use of criteria in practice based on a survey study in IGOS5
Eculizumab as a Disease‐Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report5
Abstracts of the 33rd annual meeting of the Japanese peripheral nerve society (JPNS)5
Issue Information5
Chronic inflammatory demyelinating polyneuropathy with hypertrophic nerves5
5
Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patients4
A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot–Marie–Tooth neuropathy 1A4
4
Validation of the parent‐proxy pediatric Charcot‐Marie‐Tooth disease quality of life outcome measure4
Unusual upper limb features in SORD neuropathy4
Corneal confocal microscopy in small and mixed fiber neuropathy—Comparison with skin biopsy and cold detection in a large prospective cohort4
3
Abstract3
VitaminB6levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy3
Wearables, sensors, and smart devices for the detection and monitoring of chemotherapy‐induced peripheral neurotoxicity: Systematic review and directions for future research3
3
Issue Information3
Nerve ultrasound as a screening tool for inherited sensory neuronopathy3
Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study3
A 21‐bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease course3
The neuropathy in hereditary transthyretin amyloidosis: A narrative review3
Issue Information3
Dorsal root ganglia CSF1+ neuronal subtypes have different impact on macrophages and microglia after spared nerve injury3
Development of a functional outcome measure for riboflavin transporter deficiency2
Leptospirosis‐induced acute acquired inflammatory neuropathy2
Cytokine Signature Unveils Subgroups of Patients With Immune‐Mediated Sensory Neuronopathies2
The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy2
Issue Information2
Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders2
Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies2
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome2
Ofatumumab for treating autoimmune nodopathy2
No evidence of improvement in neuropathy after renal transplantation in patients with end stage kidney disease2
Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology2
Differential Impact of Metabolic Factors and Comorbidities on Peripheral Neuropathy2
Hip Dysplasia in Charcot–Marie–Tooth Disease: Insights From a Large Cohort of Children and Adolescents2
Autoimmune nodo‐paranodopathies 10 years later: Clinical features, pathophysiology and treatment2
Associations of Guillain‐Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database2
2
Minimal invasive biopsies are highly sensitive for amyloid detection in hereditary transthyretin amyloidosis with polyneuropathy2
Digital nerve reconstruction with a new composite silk fibroin nerve conduit2
Serum anti‐GM2 and anti‐GalNAc‐GD1a ganglioside IgG antibodies are biomarkers for immune‐mediated polyneuropathies in cats2
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision2
A call to action for peripheral neuropathy research funding—Time to consolidate funding under one NIH initiative?2
Current profile of Charcot‐Marie‐Tooth disease in Africa: A systematic review2
Initial findings using high‐resolution magnetic resonance imaging for visualisation of the sural nerve and surrounding anatomy in healthy volunteers at 7 Tesla2
Prediction of respiratory failure and prolonged mechanical ventilation in Guillain‐Barré syndrome: A prospective cohort study in Bangladesh2
Vitamin D levels do not correlate with severity of idiopathic peripheral neuropathy2
Loss of MEGF10 Decreases the Number of Perisynaptic Schwann Cells and Innervation of Neuromuscular Junctions in Aging Mice2
Charcot‐Marie‐Tooth disease: Genetic profile of patients from a large Brazilian neuromuscular reference center1
Diagnostic value of nerve conduction study in NOTCH2NLC‐related neuronal intranuclear inclusion disease1
PNS Abstracts 20241
1
A deep intronic variant in MME causes autosomal recessive Charcot–Marie–Tooth neuropathy through aberrant splicing1
Abstracts of the 32nd Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)1
1
Identification of blood metabolic biomarkers associated with diabetic distal symmetric sensorimotor polyneuropathy in patients with type 2 diabetes mellitus1
Vestibular impairment in Guillain‐Barré syndrome1
Mutational screening of Greek patients with axonal Charcot‐Marie‐Tooth disease using targeted next‐generation sequencing: Clinical and molecular spectrum delineation1
Description of a patient cohort with Hereditary Sensory Neuropathy type 1 without retinal disease Macular Telangiectasia type 2 ‐ implications for retinal screening in HSN11
1
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience1
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy‐induced painful peripheral neuropathy1
Conduction block and temporal dispersion in a SIGMAR1‐related neuropathy1
Expanding the genetic and clinical spectrum of SORD‐related peripheral neuropathy by reporting a novel variant c.210T>G and evidence of subclinical muscle involvement1
CYBA allelic variants are associated with severity and recovery in Guillain–Barré syndrome1
Genotype–phenotype correlations of AR‐CMT2S in a cohort of axonal Charcot–Marie–Tooth patients from Central South China1
Successful autologous hematopoietic stem cell transplantation in a refractory anti‐Caspr1 antibody nodopathy1
Targeting translation: A review of preclinical animal models in the development of treatments for chemotherapy‐induced peripheral neuropathy1
Management of Guillain–Barré syndrome in Bangladesh: Clinical practice, limitations and recommendations for low‐ and middle‐income countries1
Identification of cellular and noncellular components of mature intact human peripheral nerve1
Issue Information1
Axolemmal nanoruptures arising from paranodal membrane injury induce secondary axon degeneration in murine Guillain‐Barré syndrome1
Adult‐onset Krabbe disease presenting as isolated sensorimotor demyelinating polyneuropathy: A case report1
Abstracts of the 35th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)1
Assessing corneal dendritic cells in glucose dysregulation small‐fibre neuropathy1
Proximal weakness involvement in the first Italian case of Charcot‐Marie‐Tooth 2CC harboring a novel frameshift variant in NEFH1
Effectiveness of exercise therapy for individuals diagnosed with Charcot–Marie–Tooth disease: A systematic review of randomized clinical trials1
Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy1
Correction to “Earlier diagnosis of peripheral neuropathy in primary care: A call to action”1
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis1
Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv presymptomatic carriers: Relationships with predicted time of disease onset (PADO)1
1
Issue Information1
A longitudinal and cross‐sectional study of plasma neurofilament light chain concentration in Charcot‐Marie‐Tooth disease1
Epidemiology of chronic inflammatory demyelinating polyradiculoneuropathy in The Netherlands1
Mitofusin 1 overexpression rescues the abnormal mitochondrial dynamics caused by the Mitofusin 2 K357T mutation in vitro0
The NCX1 calcium exchanger is implicated in delayed axotomy after peripheral nerve stretch injury0
Recent advances in the treatment of Charcot‐Marie‐Tooth neuropathies0
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial0
The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ): Reply to letter to the Editor0
Serum neurofilament light chain measurements following nerve trauma0
Acute small fiber neuropathy after Oxford‐AstraZeneca ChAdOx1‐S vaccination: A report of three cases and review of the literature0
0
Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE)0
Issue Information0
0
GJB1 variants in Charcot‐Marie‐Tooth disease X‐linked type 1 in Mali0
Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis0
The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ) for identifying pure small fiber neuropathy0
Severe distinct dysautonomia in RFC1‐related disease associated with Parkinsonism0
Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?0
Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency0
Validation of the parent‐proxy version of the pediatric Charcot‐Marie‐Tooth disease quality of life instrument for children aged 0–7 years0
0
Issue Information0
Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy0
Digenic FLNA and UCHL1 variants resulting in a complex phenotype0
Assessing diabetic polyneuropathy in Spanish‐speaking patients: Translation and validation of the Toronto Clinical Neuropathy Score0
Normal structure and pathological features in peripheral neuropathies0
IgM anti‐MAG± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protei0
EGR2 gene‐linked hereditary neuropathies present with a bimodal age distribution at symptoms onset0
Peripheral neuropathy, an independent risk factor for falls in the elderly, impairs stepping as a postural control mechanism: A case‐cohort study0
Nodal–paranodal antibodies in HIV‐immune mediated radiculo‐neuropathies: Clinical phenotypes and relevance0
DNMT1‐associated sensory neuropathy and cerebellar ataxia: A novel variant and review of genotype–phenotype correlation0
Knowledge gaps in diagnosing chronic polyneuropathy: Review of national guidelines0
Clinical and laboratory findings in scrub typhus associated Guillain‐Barré syndrome in South Korea0
Issue Information0
Issue Information0
Charcot–Marie–Toothneuropathies: Current gene therapy advances and the route toward translation0
0
A novel de novo variant in POLR3B gene associated with a primary axonal involvement of the largest nerve fibers0
Pain hypersensitivity, sensorimotor impairment, and decreased muscle force in a novel rat model of radiation‐induced peripheral neuropathy0
An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy0
Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes0
0
Inter‐rater reliability of the Rasch‐modified medical research council scoring criteria for manual muscle testing in neuromuscular diseases0
Acute nitrous oxide‐induced neuropathy mimicking Guillain‐Barré syndrome0
Issue Information0
2021 Peripheral Nerve Society virtual event0
Neurological Performance and Clinical Outcomes Related to Patients With Oropouche‐Associated Guillain–Barré Syndrome0
Physical exercise halts further functional decline in an animal model for Charcot–Marie–Tooth disease 1X at an advanced disease stage0
Hereditary neuropathies: A pathological perspective0
Correction to “Rasch‐built overall disability scale for POEMS syndrome (POEMS‐RODS)”0
Paraneoplastic Leucine Zipper 4 IgG Associated Motor‐Predominant Polyradiculoneuropathy0
Correction to ‘Serum neurofilament light chain measurements following nerve trauma’0
Clinical features of a family with late‐onset distal hereditary motor neuropathy harboring p.Pro39Leu variant of HSPB10
The endogenous calpain inhibitor calpastatin attenuates axon degeneration in murineGuillain‐Barrésyndrome0
An approach to assessing immunoglobulin dependence in chronic inflammatory demyelinating inflammatory polyneuropathy0
A previously unreported NARS1 variant causes dominant distal hereditary motor neuropathy in a French family0
The effect of tremor on disability assessment in chronic inflammatory demyelinating polyradiculoneuropathy0
Issue Information0
Issue Information0
Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version0
Ophthalmological involvement in wild‐type transthyretin amyloidosis: A multimodal imaging study0
Validation of the Italian version of the pediatric CMT quality of life outcome measure0
Issue Information0
Focal slowing of nerve conduction velocity in leprosy patients unveiled through multisegmented nerve analysis0
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis0
Nodes of Ranvier in health and disease0
Issue Information0
Variants of aminoacyl‐tRNA synthetase genes in Charcot‐Marie‐Tooth disease: A Korean cohort study0
0
Two new mouse models of Gjb1‐associated Charcot–Marie–Tooth disease type 1X0
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision0
Sensory neuronopathies: A case series and literature review0
0
Clinical, histologic, and immunologic signatures of Small Fiber Neuropathy in Systemic Lupus Erythematosus0
Liver‐directed drugs for transthyretin‐mediated amyloidosis0
Issue Information0
Long‐term safety and tolerability of hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: Results from the AD0
Association of dynamic hepatic metabolism with clinical outcomes in patients with severe Guillain‐Barré syndrome: A prospective cohort study from multi‐centers in China0
Issue Information0
Unveiling the clinical and electrophysiological profile of CMTX6: Insights from two Brazilian families0
Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response0
Genetic diversity in hereditary axonal neuropathy: Analyzing 53 Brazilian children0
Earlier diagnosis of peripheral neuropathy in primary care: A call to action0
Nerve pathology in animal models of neuropathies0
Abstracts of the 34th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)0
Unique Nerve Tissue‐Restricted T‐Cell Clones in Chronic Inflammatory Demyelinating Polyneuropathy0
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study0
Noncanonical splice‐site variant in peripheral myelin protein 22 gene (PMP22) in a patient with hereditary neuropathy with liability to pressure palsies0
Issue Information0
Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia0
Feasibility and Reliability of a Monitoring App for Chronic Inflammatory Neuropathies0
COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era0
The density of hepatic autonomic innervation differs between compensatory and direct hyperplasia rat models0
Macrophages influence Schwann cell myelin autophagy after nerve injury and in a model of Charcot‐Marie‐Tooth disease0
Feasibility of assessing progression of transthyretin amyloid polyneuropathy using nerve conduction studies: Findings from the Transthyretin Amyloidosis Outcomes Survey (THAOS)0
Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study0
Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy0
Issue Information0
Issue Information0
Neurolymphomatosis: involvement of peripheral nervous system revealing hematologic malignancy, a report of nine cases0
Phenotypic features of RETREG1‐related hereditary sensory autonomic neuropathy0
Spontaneous activity of specific C‐nociceptor subtypes from diabetic patients and mice: Involvement of reactive dicarbonyl compounds and (sensitized) transient receptor potential channel A10
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity0
Rasch‐built overall disability scale for POEMS syndrome (POEMS‐RODS)0
B‐cell and T‐cell receptor repertoire in chronic inflammatory demyelinating polyneuropathy, a prospective cohort study0
Issue Information0
0
Neutrophil‐lymphocyte ratio in Guillain‐Barré syndrome: A prognostic biomarker of severe disease and mechanical ventilation in Bangladesh0
Issue Information0
Incidence of Guillain‐Barré syndrome in an Uruguayan population. A prospective cohort study0
Nerve ultrasound in CANVAS‐spectrum disease: Reduced nerve size distinguishes genetically confirmed CANVAS from other axonal polyneuropathies0
Predicting long‐term trends in inflammatory neuropathy outcome measures using latent class modelling0
0
Changes in axonal and clinical function during intravenous and subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy0
Anxiety and depression in small fiber neuropathy0
0
Correction to “Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study”0
Issue Information0
0.049235105514526